收入
成本
利润
| Item | Category | Value | YoY |
|---|---|---|---|
| Net revenue | revenue | 819.80M | 5.39% |
| Loss before income taxes | profit | 20.11M | 284.49% |
| Operating income | profit | 5.49M | -76.31% |
| Costs and expenses | cost | 814.31M | 7.90% |
| Interest expense, net | revenue | 25.59M | -9.88% |
| Cost of net revenue | cost | 708.30M | 7.74% |
| General and administrative expenses | cost | 95.91M | 10.42% |
| Depreciation and amortization, excluding patient equipment depreciation | cost | 10.10M | -2.98% |
| Segment | Value | YoY |
|---|---|---|
| Sleep Health | 358.50M | 13.32% |
| Respiratory Health | 178.14M | 7.65% |
| Diabetes Health | 142.17M | 2.39% |
| Wellness at Home | 141.00M | -10.31% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Accounts receivable | assets | 391.97M | |
| Inventory | assets | 159.27M | |
| Prepaid and other current assets | assets | 88.28M | |
| Cash | assets | 47.96M | |
| Total current assets | assets | 687.48M | |
| Goodwill | assets | 2.57B | |
| Equipment and other fixed assets, net | assets | 622.18M | |
| Deferred income taxes, net | assets | 275.06M | |
| Operating lease right-of-use assets | assets | 122.97M | |
| Identifiable intangible assets, net | assets | 80.23M | |
| Finance lease right-of-use assets | assets | 49.92M | |
| Other assets | assets | 18.80M | |
| Total assets | assets | 4.42B | |
| Total liabilities | liabilities | 2.91B | |
| Total stockholders' equity | liabilities | 1.51B | |
| Long-term debt, less current portion | liabilities | 1.80B | |
| Total current liabilities | liabilities | 743.29M | |
| Other long-term liabilities | liabilities | 243.81M | |
| Operating lease obligations, less current portion | liabilities | 93.53M | |
| Finance lease obligations, less current portion | liabilities | 30.00M | |
| Noncontrolling interest in subsidiary | liabilities | 7.41M | |
| Total stockholders' equity attributable to adapthealth corp. | equity | 1.51B | |
| Accumulated deficit | equity | 649.01M | |
| Treasury stock, common, value | equity | 25.55M | |
| Total | liabilities | 601.39M | |
| Contract liabilities | liabilities | 59.73M | |
| Current portion of operating lease obligations | liabilities | 34.03M | |
| Current portion of long-term debt | liabilities | 24.38M | |
| Current portion of finance lease obligations | liabilities | 19.86M | |
| Other liabilities | liabilities | 3.89M | |
| Aggregate | equity | 2.18B | |
| Additional paid-in capital | equity | 2.18B | |
| Common stock, par value of $0.0001 per share, 300,000,000 shares authorized; 136,013,322 and 135,450,364 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | equity | 14000 | |
| Preferred stock, par value of $0.0001 per share, 5,000,000 shares authorized; 124,060 shares issued and outstanding as of march 31, 2026 and december 31, 2025 | equity | 1000 |
| Item | Value |
|---|---|
| Depreciation and amortization, including patient equipment depreciation | 106.47M |
| Increase (decrease) in prepaid expense and other assets | 11.91M |
| Increase (decrease) in accounts payable and accrued liabilities | 11.60M |
| Reduction in the carrying amount of operating lease right-of-use assets | 10.66M |
| Equity-based compensation | 6.53M |
| Reduction in the carrying amount of finance lease right-of-use assets | 5.05M |
| Amortization of debt issuance costs | 1.19M |
| Impairment of long-lived assets to be disposed of | 691000 |
| Other | -786000 |
| Deferred income tax expense (benefit) | -5.60M |
| Increase (decrease) in inventories | -7.75M |
| Operating lease obligations | -10.30M |
| Net loss | -14.87M |
| Increase (decrease) in accounts receivable | -21.07M |
| Item | Value |
|---|---|
| Proceeds from the sale of assets | 1.44M |
| Payments to acquire businesses, net of cash acquired | -84.68M |
| Payments to acquire property, plant, and equipment | -121.21M |
| Item | Value |
|---|---|
| Borrowings on lines of credit | 100.00M |
| Proceeds received in connection with employee stock purchase plan | 464000 |
| Payments to noncontrolling interests | -1.52M |
| Payment, tax withholding, share-based payment arrangement | -2.37M |
| Financing cash payments for finance leases | -3.10M |
| Repayments of long-term debt | -14.06M |
| Payments for tax receivable agreement | -26.85M |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 106.14M |
| Cash and cash equivalents, end of period | 47.96M |
快速穿透 10-K/10-Q 复杂数据。通过利润表及资产负债表桑基图，与现金流量表瀑布图，一站式洞悉企业财务流向。
在左侧搜索公司并选择一份报告。
申请股票支持